Emkay Global Financial's research report on AB Capital
ABCAP reported a strong set of numbers, with consolidated net income for Q4FY23 at Rs6.09bn (+36% YoY; +15%QoQ). The strong result was driven by solid operating and financial performance across business segments. The lending businesses continued their strong disbursement and loan-book growth, with improving NIM and credit costs delivering improving RoA. The life insurance business had an exceptionally strong year amid a favorable backdrop, while the health insurance franchise continued to build scale with progress on profitability. AMC segment performance was affected by the tough external environment. The Board has approved plans to raise capital up to Rs30bn to fund the company’s growth strategy.
Outlook
This capital raise is largely in line with our expectations, as the strong growth in lending requires capital infusion. With Q4FY23 performance coming on expected lines, we reiterate our BUY rating on the stock, with an unchanged Mar-24E target price of Rs200/share.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.